[go: up one dir, main page]

NL7613457A - MIXED POLYOL ESTERS. - Google Patents

MIXED POLYOL ESTERS.

Info

Publication number
NL7613457A
NL7613457A NL7613457A NL7613457A NL7613457A NL 7613457 A NL7613457 A NL 7613457A NL 7613457 A NL7613457 A NL 7613457A NL 7613457 A NL7613457 A NL 7613457A NL 7613457 A NL7613457 A NL 7613457A
Authority
NL
Netherlands
Prior art keywords
polyol esters
mixed polyol
mixed
esters
polyol
Prior art date
Application number
NL7613457A
Other languages
Dutch (nl)
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH17376A external-priority patent/CH616911A5/fr
Priority claimed from CH979076A external-priority patent/CH617175A5/en
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of NL7613457A publication Critical patent/NL7613457A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
NL7613457A 1976-01-08 1976-12-02 MIXED POLYOL ESTERS. NL7613457A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH17376A CH616911A5 (en) 1976-01-08 1976-01-08
CH979076A CH617175A5 (en) 1976-07-30 1976-07-30 Processes for the preparation of mixed polyol esters

Publications (1)

Publication Number Publication Date
NL7613457A true NL7613457A (en) 1977-07-12

Family

ID=25683750

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7613457A NL7613457A (en) 1976-01-08 1976-12-02 MIXED POLYOL ESTERS.

Country Status (18)

Country Link
JP (1) JPS5285139A (en)
BG (1) BG27537A3 (en)
CA (1) CA1075708A (en)
DD (1) DD128400A5 (en)
DE (1) DE2654951A1 (en)
EG (1) EG12290A (en)
ES (1) ES453795A1 (en)
FI (1) FI763529A (en)
FR (1) FR2337552A1 (en)
GB (1) GB1572035A (en)
GR (1) GR61818B (en)
IL (1) IL51039A0 (en)
NL (1) NL7613457A (en)
PL (1) PL117246B1 (en)
PT (1) PT65894B (en)
RO (1) RO70355A (en)
SE (1) SE7613426L (en)
YU (1) YU286476A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018683B1 (en) * 1979-04-25 1982-12-22 Shell Internationale Researchmaatschappij B.V. Process for the preparation of hydrocarbons, and hydrocarbons so prepared

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018683B1 (en) * 1979-04-25 1982-12-22 Shell Internationale Researchmaatschappij B.V. Process for the preparation of hydrocarbons, and hydrocarbons so prepared

Also Published As

Publication number Publication date
JPS5285139A (en) 1977-07-15
DD128400A5 (en) 1977-11-16
EG12290A (en) 1979-06-30
FR2337552A1 (en) 1977-08-05
PL117246B1 (en) 1981-07-31
PL194851A1 (en) 1979-05-07
FI763529A (en) 1977-07-09
BG27537A3 (en) 1979-11-12
YU286476A (en) 1982-08-31
PT65894B (en) 1978-05-18
GB1572035A (en) 1980-07-23
IL51039A0 (en) 1977-02-28
GR61818B (en) 1979-01-22
DE2654951A1 (en) 1977-07-21
RO70355A (en) 1981-08-17
CA1075708A (en) 1980-04-15
SE7613426L (en) 1977-07-09
PT65894A (en) 1976-12-01
ES453795A1 (en) 1978-01-16

Similar Documents

Publication Publication Date Title
DK589576A (en) FORM-PRESERVING BLE
FR2347459A1 (en) PR
DK258477A (en) CONTRAST AGENT
DK317589A (en) INSECTICID 2,2-DIMETHYL-3R- (2,2-DICHLORVINYL) -CYCLOPROPAN-1R-CARBOXYLIC ACID-S-ALPHA-3PHENOXYBENZYL ESTER
IT1081735B (en) CARAVAN
DK177877A (en) POLYESTER MOVIE
SE424335B (en) LINES POLYESTER COMPOSITION
SE401711B (en) GASTURBINE TRANSMISSION FACILITY
NL7701787A (en) MIXER.
SE7709565L (en) THREE GROUP POLYURETHANE PLASTS
FI65627B (en) TOEJBARA FILMER FOER FOERPACKNING AV MATVAROR
NL170770C (en) MIXER.
NL7713022A (en) QUADIC ACID ESTERS.
FI58094B (en) PAO FORDONSHJUL MONTERBAR SLIRSKYDDSANORDNING AV NAET- ELLER KEDJETYP
DK70177A (en) MIXER
SE7709071A0 (en) Olivic acid esters
NL187052C (en) MIXER.
SE401710B (en) GASTURBINE TRANSMISSION FACILITY
NL7613457A (en) MIXED POLYOL ESTERS.
NL7805705A (en) NAPHTHALENE CARBONIC ESTERS.
FI773818A (en) FOER FARAND OCH ANORDNING FOER FOERBAETTRING AV FODERVAERDET PAO SAERSKILT VAEXTSKOELKAR
BE859019A (en) MARGARINES
BE848548A (en) MIXED POLYOL ESTERS
NL7713320A (en) SPIRAMYCIN ESTERS.
NL7713655A (en) NEW ESTERS OF PHENYLETHYLAMINS.

Legal Events

Date Code Title Description
BV The patent application has lapsed